Page 161 - Read Online

Page 80 Sadaf et al. J Transl Genet Genom 2022;6:63-83 https://dx.doi.org/10.20517/jtgg.2021.36

41. Santra M, Zhan F, Tian E, Barlogie B, Shaughnessy J Jr. A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation
lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript. Blood 2003;101:2374-6. DOI PubMed
42. Keats JJ, Maxwell CA, Taylor BJ, et al. Overexpression of transcripts originating from the MMSET locus characterizes all
t(4;14)(p16;q32)-positive multiple myeloma patients. Blood 2005;105:4060-9. DOI PubMed PMC
43. Cappellen D, De Oliveira C, Ricol D, et al. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat
Genet 1999;23:18-20. DOI PubMed
44. Pei H, Zhang L, Luo K, et al. MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature
2011;470:124-8. DOI PubMed PMC
45. Avet-Loiseau H, Leleu X, Roussel M, et al. Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14)
myeloma but not outcome of patients with del(17p). J Clin Oncol 2010;28:4630-4. DOI PubMed
46. Shaughnessy J Jr, Gabrea A, Qi Y, et al. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to
immunoglobulin loci in multiple myeloma. Blood 2001;98:217-23. DOI PubMed
47. Zhan F, Huang Y, Colla S, et al. The molecular classification of multiple myeloma. Blood 2006;108:2020-8. DOI PubMed PMC
48. Mao X, Cao B, Wood TE, et al. A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and
leukemia via phosphoinositide 3-kinase pathway. Blood 2011;117:1986-97. DOI PubMed
49. Avet-Loiseau H, Malard F, Campion L, et al; Intergroupe Francophone du Myélome. Translocation t(14;16) and multiple myeloma:
is it really an independent prognostic factor? Blood 2011;117:2009-11. DOI PubMed
50. Hurt EM, Wiestner A, Rosenwald A, et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes
proliferation and pathological interactions with bone marrow stroma. Cancer Cell 2004;5:191-9. DOI PubMed
51. Walker BA, Wardell CP, Murison A, et al. APOBEC family mutational signatures are associated with poor prognosis translocations
in multiple myeloma. Nat Commun 2015;6:6997. DOI PubMed PMC
52. Ross FM, Chiecchio L, Dagrada G, et al; UK Myeloma Forum. The t(14;20) is a poor prognostic factor in myeloma but is associated
with long-term stable disease in monoclonal gammopathies of undetermined significance. Haematologica 2010;95:1221-5. DOI
PubMed PMC
53. Solvason N, Wu WW, Kabra N, Wu X, Lees E, Howard MC. Induction of cell cycle regulatory proteins in anti-immunoglobulin-
stimulated mature B lymphocytes. J Exp Med 1996;184:407-17. DOI PubMed PMC
54. Walker BA, Boyle EM, Wardell CP, et al. Mutational spectrum, copy number changes, and outcome: results of a sequencing study of
patients with newly diagnosed myeloma. J Clin Oncol 2015;33:3911-20. DOI PubMed PMC
55. Avet-Loiseau H, Gerson F, Magrangeas F, Minvielle S, Harousseau JL, Bataille R; Intergroupe Francophone du Myélome.
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood 2001;98:3082-6. DOI
PubMed
56. Dib A, Gabrea A, Glebov OK, Bergsagel PL, Kuehl WM. Characterization of MYC translocations in multiple myeloma cell lines. J
Natl Cancer Inst Monogr 2008;(39):25-31. DOI PubMed PMC
57. Walker BA, Leone PE, Chiecchio L, et al. A compendium of myeloma-associated chromosomal copy number abnormalities and their
prognostic value. Blood 2010;116:e56-65. DOI PubMed
58. Debes-Marun CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and
prognosis in myeloma. Leukemia 2003;17:427-36. DOI PubMed
59. Chng WJ, Van Wier SA, Ahmann GJ, et al. A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid
dichotomy in MGUS. Blood 2005;106:2156-61. DOI PubMed PMC
60. Onodera N, Mccabe N, Rubin C. Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia [see comments].
Blood 1992;80:203-8. PubMed
61. Chng WJ, Kumar S, Vanwier S, et al. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer
Res 2007;67:2982-9. DOI PubMed
62. Smadja NV, Bastard C, Brigaudeau C, Leroux D, Fruchart C; Groupe Français de Cytogénétique Hématologique. Hypodiploidy is a
major prognostic factor in multiple myeloma. Blood 2001;98:2229-38. DOI PubMed
63. Chretien ML, Corre J, Lauwers-Cances V, et al. Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies
really matter? Blood 2015;126:2713-9. DOI PubMed PMC
64. Pawlyn C, Melchor L, Murison A, et al. Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse
cytogenetics and may precede IGH translocations. Blood 2015;125:831-40. DOI
65. Sawyer JR, Tian E, Heuck CJ, et al. Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in
cytogenetically defined high-risk disease. Blood 2014;123:2504-12. DOI PubMed PMC
66. Schmidt TM, Barwick BG, Joseph N, et al. Gain of Chromosome 1q is associated with early progression in multiple myeloma
patients treated with lenalidomide, bortezomib, and dexamethasone. Blood Cancer J 2019;9:94. DOI PubMed PMC
67. Li C, Wendlandt EB, Darbro B, et al. Genetic Analysis of multiple myeloma identifies cytogenetic alterations implicated in disease
complexity and progression. Cancers (Basel) 2021;13:517. DOI PubMed PMC
68. Boyd KD, Ross FM, Walker BA, et al; NCRI Haematology Oncology Studies Group. Mapping of chromosome 1p deletions in
myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival. Clin
Cancer Res 2011;17:7776-84. DOI PubMed PMC
69. Fonseca R, Bergsagel PL, Drach J, et al; International Myeloma Working Group. International Myeloma Working Group molecular
classification of multiple myeloma: spotlight review. Leukemia 2009;23:2210-21. DOI PubMed PMC
70. Tricot G, Barlogie B, Jagannath S, et al. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of